S'abonner

Understanding factors associated with COVID-19 vaccination among health care workers using the Diffusion of Innovation Theory - 20/04/24

Doi : 10.1016/j.ajic.2023.11.019 
Gail C. D’Souza, DrPH a, Casey N. Pinto, PhD, MPH, NP-C a, d, Cara L. Exten, PhD b, Jessica M. Yingst, DrPH a, d, Jonathan Foulds, PhD a, c, d, Jocelyn Anderson, PhD b, Rachel Allen, PhD b, William A. Calo, PhD, JD a, d,
a Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA 
b Penn State Ross and Carol Nese College of Nursing, Penn State University, University Park, PA 
c Department of Psychiatry and Behavioral Health, Penn State College of Medicine, Hershey, PA 
d Penn State Cancer Institute, Cancer Control Program, Hershey, PA 

Address correspondence to William A. Calo, PhD, JD, Department of Public Health Sciences, Penn State College of Medicine, 90 Hope Drive, Mail Code A210, Hershey, PA 17033.Department of Public Health Sciences, Penn State College of Medicine90 Hope Drive, Mail Code A210HersheyPA17033

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Résumé

Background

The COVID-19 vaccine was initially offered to frontline health care workers (HCWs), due to the high risk of contracting COVID-19 through occupational exposure to patients. Low HCW vaccine uptake can impact overall community-level vaccine uptake. This study used the Diffusion of Innovation (DOI) Theory to understand factors related to COVID-19 vaccine uptake in HCWs.

Methods

We surveyed Pennsylvanian HCWs (excluding Philadelphia) from August 2022 to February 2023. Survey questions inquired about demographics, COVID-19 vaccination status, reasons for receiving/declining the COVID-19 vaccine, and sources of information about the vaccine.

Results

Participants (n = 3,490) were 85% female, 89% White, and 93% (n = 3,255) reported receiving at least one dose of a COVID-19 vaccine. HCWs were categorized into adopter categories of the DOI Theory: innovators (56%), early adopters (9%), early majority (11%), late majority (7%), and laggards (17%). The major reason that prompted participants to get the vaccine was to protect them against COVID-19 infection (78%), while the major reason for declining the vaccine was due to concern about possible side effects from the vaccine (78%).

Conclusions

We applied the DOI Theory to characterize adopters and identify factors related to COVID-19 vaccine uptake in HCWs. As updated COVID-19 vaccines are approved for the United States market, our findings may be used to improve vaccine education and communication among HCWs to support vaccine uptake.

Le texte complet de cet article est disponible en PDF.

Highlights

The Diffusion of Innovation Theory was used to characterize COVID-19 vaccine uptake.
Most health care workers were categorized as innovators and early adopters.
Factors related to COVID-19 vaccine uptake vary by category of adoption.

Le texte complet de cet article est disponible en PDF.

Key Words : Innovators, Early adopters, Vaccine refusal, Pennsylvania


Plan


 Conflicts of interest: Gail C. D’Souza: None. Casey N. Pinto: Funding for this project from Commonwealth of PA. Previous consulting work with Roche and BD, and support for attending meetings from American Sexually Transmitted Disease Association. Cara L. Exten: Funding for this project from Pennsylvania Department of Health: Frontline HCW. Jessica M. Yingst: None. Jonathan Foulds: I have funding from numerous NIH grants, unrelated to this project. (National Institute on Drug Abuse [NIDA] and NCI. I consulted Johnson & Johnson within the past 3 years, on clinical trial design, unrelated to the current paper. I received payment for providing lectures on Smoking Cessation from the University of Florida, unrelated to the present work. I received support for attending meetings as part of my NIH grant funding, unrelated to the present paper. I used my NIH grant funding to purchase products for use in clinical trials (eg, electronic cigarettes), unrelated to the current study. Jocelyn Anderson: Grant from the Pennsylvanian Department of Health (Awarded to PIs Pinto and Exten). Rachel Allen: Funding for this project from Pennsylvania Department of Health: Frontline HCW. William A. Calo: I have funding from the National Cancer Institute—grants R37CA253279, P01CA250989, R01CA254659 and R01CA268017. I also received funding from CDC—grant 6NU58DP006587–01, and Pennsylvania Immunization Coalition—no grant number. I received a one-time payment from Roche for a lecture offered in 2022. I serve as a co-leader, for the Pennsylvania HPV Vaccination Workgroup.
 Funding/support: This work was supported by the Pennsylvania Department of Health (OSP No. 221950).


© 2024  Association for Professionals in Infection Control and Epidemiology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 52 - N° 5

P. 509-516 - mai 2024 Retour au numéro
Article précédent Article précédent
  • Hospital health care workers’ use of facial protective equipment before the COVID-19 pandemic, implications for future policy
  • Ruth Barratt, Gwendolyn L. Gilbert
| Article suivant Article suivant
  • SARS-CoV-2 infection in health care workers during the first 2-years of the pandemic at a cancer hospital in Mexico
  • Cyntia Ibanes-Gutierrez, Nancy Martínez-Rivera, Alexandra Martin-Onraet, Frida Rivera-Buendia, Alicia Piñeirua-Menendez, Rodrigo Villaseñor-Echavarri, Janis Serrano-Ortega, Diana Vilar-Compte

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.